91 related articles for article (PubMed ID: 9273303)
1. [Syndromic and diagnostic heterogeneity of schizophrenia].
Brazo P; Dollfus S
Encephale; 1997 Apr; 23 Spec No 2():20-4. PubMed ID: 9273303
[TBL] [Abstract][Full Text] [Related]
2. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
Petit M; Langlois S
Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
[TBL] [Abstract][Full Text] [Related]
3. Clinical heterogeneity of schizophrenia.
Dollfus S; Brazo P
Psychopathology; 1997; 30(5):275-81. PubMed ID: 9353856
[TBL] [Abstract][Full Text] [Related]
4. [Methodological constraints in evaluating anti-deficit effects].
Boyer P; Lecrubier Y; Rein W
Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
[TBL] [Abstract][Full Text] [Related]
5. [Psychopathology of schizophrenia and brain imaging].
Gross G; Huber G
Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
[TBL] [Abstract][Full Text] [Related]
6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
7. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
8. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of treatment effects in schizophrenia.
Stroup TS
Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
[TBL] [Abstract][Full Text] [Related]
10. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
11. [Diagnostic principles for differential therapy of psychoses].
Hell D; Bridler R
Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
[TBL] [Abstract][Full Text] [Related]
12. [The disease "picture" of schizophrenia. Change due to operational diagnostic systems and effects on research in epidemiology and disease course].
Steinert T
Psychiatr Prax; 1998 Jan; 25(1):3-8. PubMed ID: 9530761
[TBL] [Abstract][Full Text] [Related]
13. [Alexithymia in negative symptom and non-negative symptom schizophrenia].
Nkam I; Langlois-Thery S; Dollfus S; Petit M
Encephale; 1997; 23(5):358-63. PubMed ID: 9453928
[TBL] [Abstract][Full Text] [Related]
14. [Clinical assessment of schizophrenic syndrome (CASS): validity evaluation of the new diagnostic tool].
Wciórka J; Anczewska M; Bembenek A; Gołebiewska M; Hochlewicz A; Nurowska K; Schaeffer E; Skowrońska J; Stanikowska I; Tarczyńska K
Psychiatr Pol; 2000; 34(2):203-21. PubMed ID: 10974936
[TBL] [Abstract][Full Text] [Related]
15. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses.
Gogtay N; Sporn A; Clasen LS; Nugent TF; Greenstein D; Nicolson R; Giedd JN; Lenane M; Gochman P; Evans A; Rapoport JL
Arch Gen Psychiatry; 2004 Jan; 61(1):17-22. PubMed ID: 14706940
[TBL] [Abstract][Full Text] [Related]
16. [Psychopathological profile of acute schizophrenic syndromes diagnosed according to ICD-10 and DSM-IV criteria].
Wciórka J; Anczewska M; Bembenek A; Gołebiewska M; Hochlewicz A; Nurowska K; Schaeffer E; Skowrońska J; Stanikowska I; Tarczyńska K
Psychiatr Pol; 1998; 32(3):251-64. PubMed ID: 9739178
[TBL] [Abstract][Full Text] [Related]
17. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
18. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
19. [Quality of life of schizophrenic patients and clozapine].
Raoul Y; Manesse P; Delage M
Encephale; 1997 Sep; 23 Spec No 4():12-6. PubMed ID: 9417398
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
